Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07591480 · ClinicalTrials.gov registry record
Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- 20
- Enrollment target
NCT07591480: Clinical Trial study, sponsored by M.D. Anderson Cancer Center.
NCT07591480 is a clinical trial that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07591480 has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from different racial or ethnic backgrounds, people with lower incomes, people who live in rural areas, and people who speak different languages. Investigators interview participants to learn about their experiences with clinical trials. By learning from them, investigators hope to find better ways to help more people learn about, join, and stay in clinical trials so that research is fair and helpful for everyone.
Primary Outcome
Identification of specific opportunities for improvement to increase study enrollment.
Interventions
- OTHER Interviews
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05-01 |
| Est. Completion | 2028-10-01 |
What is known before NCT07591480 opens enrollment
NCT07591480 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Interviews is the first listed.
NCT07591480 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07591480 about?
NCT07591480 is a clinical study titled "Barriers And Facilitators To Clinical Trial Enrollment: A Qualitative Study Of Pancreatic Cancer Patients". The purpose of this research is to understand why some groups of people do not join clinical trials as much as others. These groups can include people from different racial or ethnic backgrounds, people with lower incomes, people who live in rural areas, and people who speak different languages. Inv...
What is the current status of trial NCT07591480?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-05-01. Estimated completion is 2028-10-01.
What interventions are being tested in trial NCT07591480?
The interventions under investigation include: Interviews (OTHER).
Who is sponsoring clinical trial NCT07591480?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI